1.88%QQQQ 28.34 
0.11%XLF 11.75 1.43%
The Global Business News Leader | Wednesday, 19 Nov 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
EXELIXIS INC
EXEL (NASDAQ)
$ 2.98 
Change: -0.02 -0.67% | Volume: 824,674
Change: -0.02 -0.67% | Volume: 824,674
Sponsored by 
EXELIXIS INC. - Report History
General
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 117.53 | 113.47 | 98.67 | 75.96 | 52.85 | 51.54 | 44.32 |
| Depreciation & Amort ($Mil): | 11.13 | 11.13 | 16.91 | 17.75 | 17.49 | 17.74 | 16.70 |
| Operating Income ($Mil): | -182.76 | -156.84 | -125.93 | -92.90 | -105.77 | -94.66 | -86.45 |
| Net Income ($Mil): | -144.82 | -86.38 | -101.49 | -84.40 | -137.24 | -86.13 | -86.13 |
| Earnings Per Share ($): | -1.37 | -0.87 | -1.17 | -1.07 | -1.89 | -1.45 | -1.52 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 117.44 | 283.78 | 262.25 | 210.36 | 163.95 | 244.09 | 223.39 |
| Current Liabilities ($Mil): | 118.88 | 132.88 | 111.43 | 108.75 | 63.79 | 54.12 | 50.23 |
| Long Term Debt ($Mil): | 21.43 | 20.74 | 23.07 | 106.85 | 21.39 | 14.43 | 58.97 |
| Shares Outstanding (000): | 106650 | 104520 | 95780 | 83130 | 74810 | 71080 | 57440 |
| Common Equity ($Mil): | -26.95 | 72.08 | 52.54 | 33.54 | 50.67 | 161.48 | 175.92 |
Ratios
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -123.22 | -76.13 | -102.86 | -111.11 | -259.68 | -183.88 | -194.34 |
| Return on Equity (%): | -702.41 | -119.84 | -193.17 | -251.64 | -270.85 | -58.69 | -48.96 |
| Return on Assets (%): | -47 | -20.96 | -25.67 | -25.37 | -47.11 | -26.49 | -25.40 |
| P/E Ratio: | 0 | -12.02 | -8.44 | -7.24 | -4.51 | -4.99 | 0.00 |
| Price/Book: | 0 | 15.17 | 17.99 | 19.21 | 12.59 | 3.18 | 0.00 |
| Debt Equity: | -0.80 | 0.29 | 0.44 | 3.19 | 0.42 | 0.09 | 0.34 |
| Interest Coverage: | 0.00 | -27.04 | -23.73 | -14.32 | -24.56 | -24.57 | -28.35 |
| Book Value ($): | -0.25 | 0.69 | 0.55 | 0.40 | 0.68 | 2.27 | 3.06 |
| Price/Sales: | 6.03 | 2.72 | 9.58 | 8.48 | 12.07 | 9.97 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
EXEL
Companies
IBT
- Goldmans Top Execs Reject 08 Bonuses
- Citigroup Shares Plunge 6 Pct on 53,000 Job Cuts
- Target Falls in 3Q In Line with Retail Sector
- Oil lingers near $55 as investors mull recession
- Japan slides into recession, 1st time since 2001
- Full Text: SEC Complaint against Mark Cuban for Insider Trading
- Home Depot Expected to Report Loss, Similar to Lowes and Target
- Goldmans Top Execs Reject 08 Bonuses
- Citigroup Shares Plunge 6 Pct on 53,000 Job Cuts
- Mexico will recover from economic crisis by 2010: KPMG
- Obama scores big ratings for CBS interview
- Target Falls in 3Q In Line with Retail Sector
- Yahoo's fate riding on Yang's successor as CEO
- Lack of Direction from G-20 Meeting Triggers Rally in Undervalued British Pound
Top Competitors
| AMGEN |  |
+12.60 | 58.23 |
| GILEAD SCIENCES |  |
-1.00 | 46.92 |
| CELGENE CP | |
-10.00 | 58.86 |
| BIOGEN IDEC INC | |
-31.90 | 43.52 |
| AMYLIN PHARMA I | |
-85.70 | 6.41 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives